ZBTB33 多克隆抗体

免疫组织化学（IHC）已验证样本:Human colorectal cancer,Human cervical cancer

IHC 1:40-1:200, ELISA 1:5000-1:10000

Polyclonal

IgG

Synthetic peptide of human ZBTB33

ZBTB33

Kaiso;Kaiso protein;Kaiso transcription factor;KAISO;Transcriptional regulator Kaiso;ZBTB 33;Zbtb33;Zinc finger and BTB domain containing 33;Zinc finger and BTB domain-containing protein 33;Zinc finger transcription factor Kaiso;ZNF 348;ZNF Kaiso;ZNF348抗体

Q86T24

Nucleus. Cytoplasm. Also cytoplasmic in cells grown at high densities.

0.9 mg/mL

在-20℃下储存有效期为12个月。 避免冻融循环。

PBS with 0.05% NaN3 and 40% Glycerol,pH7.4

Antigen affinity purification

Cancer; Epigenetics and Nuclear Signaling

Unconjugated

This gene encodes a transcriptional regulator with bimodal DNA-binding specificity, which binds to methylated CGCG and also to the non-methylated consensus KAISO-binding site TCCTGCNA. The protein contains an N-terminal POZ/BTB domain and 3 C-terminal zinc finger motifs. It recruits the N-CoR repressor complex to promote histone deacetylation and the formation of repressive chromatin structures in target gene promoters. It may contribute to the repression of target genes of the Wnt signaling pathway, and may also activate transcription of a subset of target genes by the recruitment of catenin delta-2 (CTNND2). Its interaction with catenin delta-1 (CTNND1) inhibits binding to both methylated and non-methylated DNA. It also interacts directly with the nuclear import receptor Importin-α2 (also known as karyopherin alpha2 or RAG cohort 1), which may mediate nuclear import of this protein. Alternatively spliced transcript variants encoding the same protein have been identified.